Norwegian University of Life Sciences, AS, Norway.
Faculty of Medicine, Universiti Sultan Zainal Abidin, Kuala Terengganu, Malaysia.
Curr Pharm Des. 2022;28(31):2519-2537. doi: 10.2174/1381612828666220728104200.
Molecular hydrogen proved itself as a novel therapeutic candidate and has been thriving from the beginning with its potential clinical significance, higher affinity, and cellular integrity and permeability. Hydrogen Therapy (HT) has gained scientists' attention with the proven clinical ability to attenuate chronic inflammation, diminish oxidative stress, restrict apoptosis, minimize cellular injury, and refine tissue functioning. Therapeutic Implementation of H for disease prevention and treatment is a newly emerging field with limited knowledge available on formulations, tissue-specific effects, efficacy, and safety. This article will discuss HT's therapeutic potential for its efficacy and safety in cardiovascular, respiratory, hematological, metabolic, infectious, and neurodegenerative disorders. In addition to this, the molecular mechanisms and nanotechnological implications of hydrogen therapy will be discussed in detail. Finally, the article will provide insight into advancements and automation, future perspectives, and recommendations. There is a need to study and conduct higher-scale trials targeting personalized treatments under molecular and genetic vitals.
分子氢已被证明是一种新型的治疗候选物,从一开始就因其潜在的临床意义、更高的亲和力以及细胞完整性和通透性而备受关注。氢气治疗 (HT) 已经引起了科学家的注意,其已被证明具有减轻慢性炎症、减少氧化应激、限制细胞凋亡、最小化细胞损伤和改善组织功能的临床能力。氢气用于疾病预防和治疗的治疗实施是一个新兴领域,关于配方、组织特异性效应、疗效和安全性的知识有限。本文将讨论 HT 在心血管、呼吸、血液、代谢、感染和神经退行性疾病中的治疗潜力及其疗效和安全性。此外,还将详细讨论氢气治疗的分子机制和纳米技术意义。最后,文章将提供对进展和自动化、未来展望和建议的深入了解。有必要针对分子和遗传关键因素下的个性化治疗进行研究和开展更高规模的试验。